📰 Skye Bioscience News
Page 5 - Skye Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Skye Bioscience. Real-time updates on events, politics, business and more.
May 27, 2023
Skye Bioscience, Inc. (OTCMKTS:SKYE – Get Rating) was the target of a significant increase in short interest in May. As of May 15th, there was short interest totalling 44,700 shares, an increase of 84.7% from the April 30th total of 24,200 shares. Based on an average trading volume of 2,032,700 shares, the days-to-cover ratio is […]
April 28, 2023
Skye Bioscience, Inc. (OTCMKTS:SKYE – Get Rating) saw a large decline in short interest in the month of April. As of April 15th, there was short interest totalling 24,200 shares, a decline of 13.3% from the March 31st total of 27,900 shares. Based on an average daily trading volume, of 3,102,700 shares, the short-interest ratio […]
April 4, 2023
Pharma Stock News: Skye Bioscience (OTCQB: SKYE) Receives Positive Safety Review of Third Cohort in Phase 1 Study of SBI-100 Ophthalmic Emulsion
April 4, 2023
If you’ve ever lost sleep over a fear of “looking bad,” take a page from the sports world: reflect on your flaws and create a plan to improve them.
April 3, 2023
San Diego, California--(Newsfile Corp. - April 3, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) (Skye or the Company), a pharmaceutical company ...
March 27, 2023
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February 16, 2023, Skye Bioscience,... | March 27, 2023
March 15, 2023
San Diego, California--(Newsfile Corp. - March 15, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative
February 23, 2023
Skye Bioscience CEO Punit Dhillon joins Natalie Stoberman from the Proactive newsroom to discuss the positive safety review for its Phase 2 clinical trial...
February 13, 2023
San Diego, California--(Newsfile Corp. - February 13, 2023) - Skye Bioscience, Inc. (OTCQB: SKYE) ("Skye" or the "Company"), a pharmaceutical company developing a proprietary, synthetic cannabinoid derivative
February 7, 2023
Skye Bioscience CEO Punit Dhillon joins Natalie Stoberman from the Proactive studio to share the latest progress on its SBI-100 Ophthalmic Emulsion clinical...